Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

243.25 -1.04 (-0.43%)
Streaming Delayed Price Updated: 1:22 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024 ↗
IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
IQVIA Reports First-Quarter 2024 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Analysts Are Pounding the Table on These 3 Stocks: April 2024 ↗
From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy. 
Via InvestorPlace
News headline image
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
From IQVIA
Via Business Wire
News headline image
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Peering Into IQVIA Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
Peering Into IQVIA Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost ↗
Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement. 
Via Benzinga
News headline image
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
From IQVIA
Via Business Wire
News headline image
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
Via The Motley Fool
News headline image
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
From IQVIA Holdings Inc.
Via Business Wire
News headline image
How Is The Market Feeling About IQVIA Hldgs? ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 14, 2024 ↗
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights ↗
 
Via Benzinga
News headline image
IQVIA Publishes its 2023 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
News headline image
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
From IQVIA
Via Business Wire
News headline image
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Expert Ratings For IQVIA Hldgs ↗
 
Via Benzinga
News headline image
(IQV) - Analyzing IQVIA Hldgs's Short Interest ↗
 
Via Benzinga
News headline image
IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗
 
Via Benzinga
News headline image
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday? ↗
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. 
Via Benzinga
Topics Economy
News headline image
Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment ↗
IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook. 
Via Benzinga
News headline image
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year
From IQVIA
Via Business Wire
News headline image
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report
From IQVIA
Via Business Wire
News headline image
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names ↗
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month. 
Via InvestorPlace
News headline image
IQVIA's Bold Merger Move Blocked As FTC's Concerns Over Competition Take Center Stage ↗
IQVIA Holdings, Inc.'s (NYSE: IQV) attempt to acquire DeepIntent, a healthcare advertising firm, was reportedly thwarted as a U.S. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.